Epidemics and pandemics due to infectious agents, be viruses or bacteria, are still a major
threat for public health. Following up on the HIV epidemics, we have experienced Zika,
Dengue,
Event Details
Epidemics and pandemics due to infectious agents, be viruses or bacteria, are still a major
threat for public health. Following up on the HIV epidemics, we have experienced Zika,
Dengue, Chikungunya, and of course SARS CoV1 and SARS Cov2 (COVID-19). COVID-19
is not completely over, and we know that there will be other epidemics and pandemics (the
USA as an example, is experiencing a severe burst of measles). Resistance to antibiotics has
also emerged as a major concern.
Microbiomes, these huge populations of bacteria which are present in all of us in the gut, the
skin and many tissues have been now well recognized to be major drivers of human health
and there is plenty of evidence showing its role in cardiovascular and neurodegenerative
diseases, as well as in cancer and other medical conditions. In addition, the composition of the
microbiomes has a very significant impact on the sensitivity to infectious diseases as well as
vaccine efficacy. Importantly, it is possible to intervene on these microbiomes through propre-postbiotics as well as transplantation of intestinal microbiota. Some of these molecules
not only act on the gut microbiota but show systemic effects (tissue repair, anti-inflammatory)
which can offer novel treatments to diseases such as Alzheimer’s.
This lecture will describe how viral infections and microbiomes are entangled and what
can be the impact for treating both infectious diseases and chronic diseases, such as
neurodegenerative diseases
